Trials / Completed
CompletedNCT01286129
Nasal Allergen Challenge in Rhinitic Subjects
Comparative Responses to Nasal Allergen Challenge in Allergic Rhinitic Subjects With or Without Asthma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Background: Nasal allergen challenge (NAC) is useful to study the pathophysiology of rhinitis, and multiple challenges may more adequately approximate natural exposure. Objective: To determine the effect of 4 consecutive daily NAC, on clinical and inflammatory parameters in rhinitics with or without asthma.
Detailed description
The study will be performed outside the pollen season. On a baseline visit, 2 to 7 days prior to control challenge, allergy skin prick tests and methacholine inhalation test will be done. Prior to first allergen challenge, skin titration will be done using tenfold dilutions of the allergen chosen for nasal challenges. Subsequent to baseline visit, a control challenge will be done, followed, a week later, by repeated NACs. NACs will be done over 4 consecutive days, in the morning. Nasal peak inspiratory flows (NPIF), oral peak expiratory flows (PEF), and symptoms will be recorded at baseline and at regular intervals over 7 hours post-challenge on each challenge day. Induced sputum and nasal lavage specimen will be obtained 7 hours following the control challenge and the first and last NAC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Nasal allergen challenge | Allergen sprayed into nostrils. Allergen used will be house dust mite or cat allergen. Allergens will be given in increasing ten-fold dilutions until a positive response occurs. |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2011-01-31
- Last updated
- 2019-02-01
- Results posted
- 2013-07-01
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01286129. Inclusion in this directory is not an endorsement.